gildfan

Too Much Optimism for Gilead Sciences?

Well, go ahead short this, what ever your charts show. I'm not going to short this stock. This company has a strong cash position and they make the best AIDS drugs on the planet. Maybe not the deepest pipeline, but better than most. I think they'll get up to at last 55$/share this year with some ups and downs as the market fluctuates. They've bounced back fairly nicely from the recent downturn, they're only approx. 5$/share off from where they were this summer, they were down around18$/share in early/mid October.
Unless the unforseen comes up I think this stock will be in the mid 50's by this summer with not alot of chances to short.